Nov 2019

ANTG PASSES THE TGA’S QUALITY STANDARDS

We’re pleased to announce we have successfully passed the TGO93 and TGO100 mandatory tests for our first commercial export crop. TGO93 and TGO100 specify the standard for quality requirements for medicinal cannabis products. Implemented by the Therapeutic Goods Administration (TGA), these standards ensure all medicinal cannabis manufacturers provide the highest quality and reliability in therapeutics goods on the market. We’re firmly on course for our first European export by the end of this year.

Australian Natural Therapeutics Group (ANTG) will ship locally cultivated and […]

READ MORE >

Two medicinal marijuana companies have fast-tracked plans to build a […]

READ MORE >

ANTG APPOINTS JUSTIN SINCLAIR AS CHIEF SCIENTIFIC OFFICER Australian Natural […]

READ MORE >

We are focused on research and development, partnering with leading scientists and medical institutions to develop cannabinoid medicines that offer safe and effective therapeutic benefits.

LEARN ABOUT ANTG HERE >